MedPath

Expressive Helping for Chinese-Speaking Cancer Patients and Survivors

Not Applicable
Completed
Conditions
Cancer
Neoplasms
Interventions
Behavioral: Expressive Helping
Registration Number
NCT03945734
Lead Sponsor
New York University
Brief Summary

This study examines the feasibility, cultural-sensitivity, and health effects of the expressive helping intervention by conducting a single-arm trial with Chinese-speaking cancer patients and survivors.

Detailed Description

This study examines whether expressive helping is feasible and culturally-sensitive for Chinese American cancer patients and survivors. For 20 minutes each week over four weeks, participants choose to write or voice-record their thoughts about cancer by following specific prompts designed to help them process their cancer experiences. During the last week of this reflection exercise, participants write or voice-record an anonymous letter to another Chinese cancer patient by sharing their cancer experience and providing advice and encouragement. Health outcomes are assessed at baseline, 1-month, and 3-month follow-ups. A subset of the participants will be invited to share their experiences with the study through qualitative interviews after the last writing/voice-recording session. This research study provides an opportunity for Chinese American cancer patients and survivors to express their feelings without the fear of burdening others, and give them an opportunity to help others by sharing their cancer experiences.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Diagnosis of cancer (any type)
  • Of Chinese descent
  • Over the age of 18
  • Can speaking and read Mandarin Chinese
Exclusion Criteria
  • Completed primary cancer treatment more than five years ago

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Expressive HelpingExpressive HelpingParticipants complete four 20-minute writing/voice-recording sessions spaced one week apart. During the first week, the instructions will explain that cancer patients and survivors benefit from learning about other cancer survivors' experiences. They are told that the first three weeks of writing/voice-recording (writing/talking about their stress and coping at Week 1, deepest emotions about cancer at Week 2, self-affirmation and benefit finding at Week 3) are exercises designed to help them think about their cancer experiences and to prepare them to write/record the narrative they would share on Week 4. During Week 4, they are asked to write/record a narrative as if they are speaking to another Chinese person with cancer, adding advice and encouragements, and reminded that their writing/recording would be shared with other Chinese American cancer patients and survivors.
Primary Outcome Measures
NameTimeMethod
Meaningfulness of the studyThis will be assessed approximately four weeks after the baseline

We will ask participants open-ended questions about whether they felt participating in this study was meaningful to them.

Retention ratethrough study completion, an average of 1 year

Retention rate is calculated by dividing the number of participants who began the study by the number of participants who finished the entire study.

Number of participants screenedthrough study completion, an average of 1 year

The number of participants screened for eligibility will be counted.

Compliance ratethrough study completion, an average of 1 year

Compliance rate is calculated by dividing the number of writing/voice-recording sessions finished by the number of sessions assigned.

Secondary Outcome Measures
NameTimeMethod
Change in quality of life as assessed by the Functional Assessment of Cancer Therapy Scale (FACT).Baseline; 1-month follow-up; 3-month follow-up

The Functional Assessment of Cancer Therapy Scale (FACT) is a 27-item measure of health-related quality of life (Cella \& Tulsky,1993). This scale assesses contains four different subscales, including physical well-being (7 items), social well-being (7 items), emotional well-being (6 items), and functional well-being (7 items).

Change in depressive symptoms as assessed by the Center for Epidemiologic Studies Depression Scale (CES-D).Baseline; 1-month follow-up; 3-month follow-up

The CES-D (Radloff, 1977) is a 20-item measure of depressive symptoms.

Trial Locations

Locations (1)

New York University

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath